Improving the diagnosis of endometriosis is currently one of the major challenges in research on this disease.
Due to the diversity of symptoms and the heterogeneity of clinical presentations, diagnosing endometriosis remains complex and frequently delayed. Numerous research initiatives are currently underway to identify new biomarkers that could enable earlier and more accurate diagnosis.
Within FHU FRAME, several projects aim to develop and validate new diagnostic approaches. These studies rely in particular on the analysis of standardized clinical and radiological data, the identification of molecular biomarkers, and the investigation of the pathophysiological mechanisms underlying the disease.
In the long term, this research could help reduce diagnostic delays, improve patient stratification, and facilitate earlier referral of women to appropriate care pathways.
By strengthening collaborations between clinicians, researchers, and institutional partners, FHU FRAME actively contributes to advancing research and improving the management of patients with endometriosis.